FDA Inspection 1002865 — Lazzaro, Marc, MD
The FDA completed an inspection of Lazzaro, Marc, MD on February 15, 2017 in Milwaukee, WI. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Devices.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 15, 2017
- Fiscal Year
- 2017
- Product Type
- Devices
- Project Area
- Bioresearch Monitoring
- Location
- Milwaukee, WI (United States)
Additional Details
Clinical Investigator (CI)